Overall Patient Characteristics
| No. of patients | 21 |
| Median age (yr) | 36 |
| Sex (male/female) | 10/11 |
| Diagnosis | |
| AML | 5 |
| ALL | 4 |
| CML | 8 |
| NHL | 3 |
| SAA | 1 |
| Conditioning regimen | |
| CY/fTBI | 18 |
| CY/VP16/fTBI | 3 |
| GVHD prophylaxis | |
| CSA/MTX | 17 |
| CSA | 3 |
| CSA/Pred | 1 |
| BM donors | |
| Serologic and LBT match | 18 |
| Serologic and LBT mismatch | 3 |
| Related/unrelated | 12/9 |
| Sex mismatch | 13 |
| Female donor to male recipient | 7 |
| Median donor age (yr) | 38 |
| Range | 20-62 |
| No. of patients | 21 |
| Median age (yr) | 36 |
| Sex (male/female) | 10/11 |
| Diagnosis | |
| AML | 5 |
| ALL | 4 |
| CML | 8 |
| NHL | 3 |
| SAA | 1 |
| Conditioning regimen | |
| CY/fTBI | 18 |
| CY/VP16/fTBI | 3 |
| GVHD prophylaxis | |
| CSA/MTX | 17 |
| CSA | 3 |
| CSA/Pred | 1 |
| BM donors | |
| Serologic and LBT match | 18 |
| Serologic and LBT mismatch | 3 |
| Related/unrelated | 12/9 |
| Sex mismatch | 13 |
| Female donor to male recipient | 7 |
| Median donor age (yr) | 38 |
| Range | 20-62 |
Abbreviations: AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; CML, chronic myeloid leukemia; NHL, non-Hodgkin’s lymphoma; SAA, severe aplastic anemia; CY, cyclophosphamide; fTBI, fractionated total body irradiation; VP16, etoposide; CSA, cyclosporine A; MTX, methotrexate; Pred, methylprednisone; BM, bone marrow; LBT, ligation based typing of class II.